Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59,000 KRW | +0.68% | -0.84% | -12.33% |
05-09 | SK Chemicals Swings to Loss in Q1 | MT |
04-26 | SK chemicals Unveils Blueprint for Circular Recycle? and Solutions | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.33% | 781M | |
-20.44% | 21.93B | |
-13.38% | 13.45B | |
-9.15% | 10.2B | |
-8.49% | 9.8B | |
+16.16% | 8.02B | |
+10.42% | 6.91B | |
-23.95% | 5.78B | |
-29.11% | 3.37B | |
-22.78% | 3.33B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.